Giant axonal neuropathy (GAN) is a neurodegenerative disorder classified within the hereditary motor and sensory neuropathies, affecting both the peripheral and central nervous systems. GAN typically presents in early childhood before the age of five years and progresses to death usually by early adulthood. Various imaging findings in giant axonal neuropathy have been described and documented in literature in the form multiple case reports. We here present a pictorial essay of all the major imaging GAN findings described in the literature. In addition, involvement of the dentate nucleus hitherto not described in the literature was noted in the present case.
BoltshauserEBischoffAIslerW: Giant axonal neuropathy, report of a case with normal hair. J Neurol Sci31: 269–78, 1977.
2.
MalandriniADottiMTBattistiC: Giant axonal neuropathy with subclinical involvement of the central nervous system: A case report. J Neurol Sci158: 232–5, 1998.
3.
PeifferJSchloteWBischoffA: Generalized giant axonal neuropathy. A filament-forming disease of neuronal, endothelial, glial and Schwann cells in a patient without kinky hair. Acta Neuropathol (Berl)40: 213–18, 1977.
4.
BomontPKoenigM: Intermediate filament aggregation in fibroblasts of giant axonal neuropathy patients is aggravated in non dividing cells and by microtubule destabilization. Hum Mol Genet12: 813–22, 2003.
5.
LamplYEshelYDavidBen E: Giant axonal neuropathy with predominant central nervous system manifestations. Dev Med Child Neurol34: 164–81, 1992.
Trebier-HeldSBudjarjo-WelimRiemannD: Giant axonal neuropathy: A generalised disorder of intermediate filaments with longitudinal grooves in the hair. Neuropediatrics25: 89–93, 1994.
8.
StollhoffKAlbaniMGoebelHH: Giant axonal neuropathy and leukodystrophy. Pediatr Neurol7: 69–71, 1991.
9.
NCBI, Bookshelf, GeneReviews, Giant Axonal Neuropathy, Gregor Kuhlenbäumer, MD, PhD August 11, 2009.
10.
AllenEDingJWangW: Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival. Nature438: 224–8, 2005.
11.
DingJAllenEWangW: Gene targeting of GAN in mouse causes a toxic accumulation of microtubule-associated protein 8 and impaired retrograde axonal transport. Hum Mol Genet15: 1451–63, 2006.
12.
MarjoSVan der Knaap: Magnetic resonance of myelination And myelin disorders, third editions.
13.
DemirEBomontPErdemS: Giant axonal neuropathy: Clinical and genetic study in six cases. J Neurol Neurosurg Psychiatry76: 825–32, 2005.
14.
NeilG: Giant axonal neuropathy: A review. Dev Med Child Neurol46: 717–19, 2004.
15.
BomontPCavalierLBlondeauF: The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet26: 370–4, 2000.
16.
RavishankarSGoelGRautenstraussCPB: Spectrum of magnetic resonance imaging findings in a family with giant axonal neuropathy confirmed by genetic studiesNeurology India57, 2: 181–184, 2009.
17.
AlkanASigirciAKutluR: Giant axonal neuropathy: Diffusion weighted imaging features of the brain. J Child Neurol21: 91, 2006.
BrockmanKPouwelsPJDechentP: Cerebral proton magnetic resonance spectroscopy of a patient with giant axonal neuropathy. Brain Dev25, 45: 25: 45–50, 2003.
20.
HouldenHenryGrovesMMiedzybrodzkaZ: New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy. J Neurol Neurosurg Psychiatry78: 1267–1270 doi: 10.1136/jnnp.2007. 118968, 2007.
21.
BrennerCSpeck-MartinsCEFarageL: 3T MR with diffusion tensor imaging and single-voxel spectroscopy in giant axonal neuropathy. J Magn Reson Imaging28 (1): 236–41, 2008.
